A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254239A2 Mammalian secreted group iii phospholipase a2
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
11/06/2002	EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002	EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002	EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254176A2 Trade molecules and uses related thereto
11/06/2002	EP1254175A1 Human cystine knot polypeptide
11/06/2002	EP1254174A2 Human cyr61
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1253948A2 Gene therapy for treating ocular-related disorders
11/06/2002	EP1253938A2 Immunization of an individual against carcinoma and the preliminary stages thereof
11/06/2002	EP0883624B1 Tetraether lipids and liposomes containing said lipids, and use of the same
11/06/2002	CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof
11/06/2002	CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
11/06/2002	CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002	CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002	CN1377707A Medicinal composition for target direction transport curing cancer and its usage
11/05/2002	US6476243 Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476205 2′ Modified oligonucleotides
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476000 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/05/2002	US6475999 Method of inducing an immune response using vaccinia virus recombinants
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475996 Use of a vector expressing DNA polymerase β as medicine
11/05/2002	US6475995 Oral delivery of nucleic acid vaccines by particulate complexes
11/05/2002	US6475798 Transposon plasmid for use as diagnostic tool and gene therapy
11/05/2002	US6475795 Use of hyaluronan in gene therapy
11/05/2002	US6475789 Human telomerase catalytic subunit: diagnostic and therapeutic methods
11/05/2002	US6475779 Polymeric gene delivery
11/05/2002	US6475769 Methods and cell line useful for production of recombinant adeno-associated viruses
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475756 Development of viruses resistant to inactivation by the human complement system
11/05/2002	US6475753 94 Human Secreted Proteins
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475740 Inducing globin gene expression in cells; obtain cells, incubate with preferential nucleotide sequences, monitor cells for amplified globin expression
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475488 Methods of inhibiting angiogenesis and ameliorating cancer by using superfibronectin
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475482 Genetically modified tumor-targeted bacteria with reduce virulence
11/05/2002	US6475481 Purging of stem cell products
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	US6475468 Modulated release particles for aerosol delivery
11/05/2002	US6475140 Flexible pressure resistant cover for the articulation system of a medical instrument
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086161A1 Method of estimating diplotype from genotype of individual
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086134A2 Buffer solution for electroporation and a method comprising the use of the same
10/31/2002	WO2002086132A2 Viral vector system to transduce or infect a target adipose tissue site
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002	WO2002086093A2 Methods of using a hyaluronan receptor
10/31/2002	WO2002086091A2 Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086064A2 Inducible expression of transfected genes
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085416A1 Viral vectors having reduced virulence
10/31/2002	WO2002085410A2 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
10/31/2002	WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs
10/31/2002	WO2002085330A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/31/2002	WO2002085287A2 Minimal adenoviral vectors for immunization
10/31/2002	WO2002068585A3 Tip39 polypeptides
10/31/2002	WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002	WO2002055535A3 Antisense modulation of cytohesin-1 expression
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002	WO2002008434A3 Bicistronic influenza comprising two genes in tandem
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002	WO2002000250A3 Hiv-1 vaccines and screening methods therefor
10/31/2002	WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002	WO2001087348A3 Multifunctional nanodevice platform
10/31/2002	WO2001078790A3 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE
10/31/2002	WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002	WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2
10/31/2002	WO2001049844A9 Compositions and methods for gene silencing
10/31/2002	US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002	US20020161200 For therapy
10/31/2002	US20020160980 Method of treating hepatitis delta virus infection

1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 870